1 |
Zhang H, Gao Y, Fu G, Liu J, Jiao Q. Trends and hotspots for European Journal of Medicinal Chemistry: A bibliometric study. Eur J Med Chem 2023;247:115041. [PMID: 36566715 DOI: 10.1016/j.ejmech.2022.115041] [Reference Citation Analysis]
|
2 |
Liu F, Xu J, Yang R, Liu S, Hu S, Yan M, Han F. New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway. Biomed Pharmacother 2023;157:114084. [PMID: 36481407 DOI: 10.1016/j.biopha.2022.114084] [Reference Citation Analysis]
|
3 |
Gao D, Asghar S, Hu R, Chen S, Niu R, Liu J, Chen Z, Xiao Y. Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.016] [Reference Citation Analysis]
|
4 |
Tuli HS, Garg VK, Mehta JK, Kaur G, Mohapatra RK, Dhama K, Sak K, Kumar A, Varol M, Aggarwal D, Anand U, Kaur J, Gillan R, Sethi G, Bishayee A. Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. OTT 2022;Volume 15:1419-1448. [DOI: 10.2147/ott.s366630] [Reference Citation Analysis]
|
5 |
Zhang L, Ye B, Chen Z, Chen Z. Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.10.002] [Reference Citation Analysis]
|
6 |
Wang KL, Yu YC, Chen HY, Chiang YF, Ali M, Shieh TM, Hsia SM. Recent Advances in Glycyrrhiza glabra (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment. Metabolites 2022;12:535. [PMID: 35736467 DOI: 10.3390/metabo12060535] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|